Patents by Inventor Jonathan Higgins

Jonathan Higgins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220213524
    Abstract: The invention provides a novel method for identifying or profiling a target cellular kinase Uses of such kinases (or their corresponding inhibitors) in diagnosis or therapy are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: July 7, 2022
    Inventors: Jonathan HIGGINS, Nikolaus WATSON
  • Publication number: 20140040725
    Abstract: An electronic billboard comprises at least one processor, at least one computer-readable tangible storage device, and program instructions stored on the at least one storage device for execution by the at least one processor. The program instructions comprise first program instructions configured to receive media content comprising text and at least one image. The program instructions further comprise second program instructions configured to separate the text and the at least one image. The program instructions further comprise third program instructions configured to cause the electronic billboard to display the text on a first predetermined portion of the electronic billboard. The program instructions further comprise fourth program instructions configured to cause the electronic billboard to display the image on a second predetermined portion of the electronic billboard.
    Type: Application
    Filed: August 5, 2013
    Publication date: February 6, 2014
    Inventors: Brian Foster, Jesse W. Nual, April Wilson, Robert Wright, Jonathan Higgins
  • Publication number: 20130231360
    Abstract: The present disclosure is directed to compounds of Formula (I) which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity.
    Type: Application
    Filed: April 21, 2011
    Publication date: September 5, 2013
    Applicant: THE BRIGHAM AND WOMEN S HOSPITAL, INC.
    Inventors: Jonathan Higgins, Debasis Patnaik, Natalia Ulyanova, Ross L. Stein, Jun Xian, Marcie Glicksman, Gregory D. Cuny
  • Publication number: 20130102627
    Abstract: The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity.
    Type: Application
    Filed: April 8, 2011
    Publication date: April 25, 2013
    Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Jonathan Higgins, Gregory D. Cuny, Marcie Glicksman, Debasis Patnaik, Maxime Robin, Ross L. Stein, Jun Xian
  • Patent number: 7655431
    Abstract: The present invention is directed to methods for increasing or decreasing the phosphorylation of histone H3 using factors that alter the activity of the kinase haspin. The invention includes assays for identifying inhibitors, peptides that can serve as inhibitors or in the generation of antibodies that specifically recognize phosphorylated histone, polynucleotides encoding peptides, procedures for increasing intracellular haspin levels, and methods for assaying haspin activity in a biological sample to determine whether abnormalities in cell division may be due to the overexpression or underexpression of haspin.
    Type: Grant
    Filed: December 5, 2005
    Date of Patent: February 2, 2010
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Jonathan Higgins, Jun Dai
  • Publication number: 20080096222
    Abstract: The present invention is directed to methods for increasing or decreasing the phosphorylation of histone H3 using factors that alter the activity of the kinase haspin. The invention includes assays for identifying inhibitors, peptides that can serve as inhibitors or in the generation of antibodies that specifically recognize phosphorylated histone, polynucleotides encoding peptides, procedures for increasing intracellular haspin levels, and methods for assaying haspin activity in a biological sample to determine whether abnormalities in cell division may be due to the overexpression or underexpression of haspin.
    Type: Application
    Filed: December 5, 2005
    Publication date: April 24, 2008
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Jonathan Higgins, Jun Dai